1)Therasse P, Arbuck SG, Eisenhauer EA, et al. New guideline to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 : 205-216, 2000
2)日本胃癌学会(編).胃癌取扱い規約,13版.金原出版,1999
3)Ohtsu A, Boku N, Miyata Y, et al. Response of the primary lesions in gastric cancer to chemotherapeutic trials. Int J Clin Oncol 3 : 3-6, 1998
4)Koizumi W, Kurihara M, Tanabe S, et al. Advantages of Japanese response criteria for estimating the survival of patients with primary gastric cancer. Gastric Cancer 2 : 14-19, 1999
5)Yoshida S, Miyata Y, Ohtsu A, et al. Significance of and problems in adopting response evaluation criteria in solid tumor RECIST for assessing anticancer effects of advanced gastric cancer. Gastric Cancer 3 : 128-133, 2000
6)小泉和三郎,栗原稔,田辺聡,他.胃癌化学療法の効果判定法─胃癌取扱い規約とRECIST.胃と腸 40 : 987-998, 2005
7)Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis─correlation in invasive breast carcinoma. N Engl J Med 324 : 1-8, 1991
8)Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340 : 145-146, 1992
9)Maeda K, Chung YS, Takatsuka S, et al. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72 : 319-323, 1995
10)Araya M, Terashima M, Takagane A, et al. Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65 : 232-236, 1997
11)Kawasaki T, Ueo T, Itani T, et al. Vascularity of advanced gastric carcinoma : evaluation by using power Doppler imaging. J Gastro Hepatol 16 : 149-153, 2001
12)Okanobu H, Hata K, Haruma K, et al. Preoperative assessment of gastric cancer vascularity by flash echo imaging. Scand J Gastroenterol 5 : 608-612, 2002
13)Nathalie L, Michele L, Linda C, et al. Gastrointestinal stromal tumors treated with imatinib : monitoring response with contrast─enhanced sonography. AJR 187 : 1267-1273, 2006
14)Rosen MA, Schnall MD. Dynamic contrast-enhanced magnetic resonance imaginig for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 13 : 770s-776s, 2007